A number of stocks fell in the afternoon session after reports pointed to a broad-based weakening of consumer health, highlighted by rising loan delinquencies and falling spending intentions.
Shares of semiconductor design software provider Cadence Design Systems (NASDAQ:CDNS) jumped 9.1% in the afternoon session after the company reported strong second-quarter results that surpassed analyst expectations and raised its full-year financial outlook. The electronic design automation (EDA) company, which provides software and hardware for designing semiconductors, posted second-quarter adjusted earnings of $1.65 per share on revenue of $1.28 billion. This revenue figure represented a 20% increase year-over-year, and both metrics beat analyst forecasts. The strong performance was attributed to high demand from the artificial intelligence, high-performance computing, and automotive sectors. This result came despite Cadence disclosing a one-time charge of $140.6 million to settle legal proceedings with the U.S. government over its business operations in China. Investors appeared to focus on the strong results, as the company also increased its 2025 revenue forecast to a range of $5.21 billion to $5.27 billion and its adjusted EPS guidance to between $6.85 and $6.95. Following the news, analysts at firms including J.P. Morgan and Wells Fargo raised their price targets.
Barclays PLC, one of the most influential financial institutions in the world today, traces its origins back over three centuries to the coffee houses and counting houses of London. From its modest beginnings as a Quaker-led partnership to becoming a pillar of international banking, Barclays has evolved through mergers, innovations,
Shares of health coverage company Centene (NYSE:CNC)
fell 3.3% in the morning session after JPMorgan cut its price target on the managed care company to $30 from $48. This move by JPMorgan followed Centene's recent second-quarter earnings report, where the company posted a loss of $0.16 per share, missing analyst estimates. The poor results were largely attributed to a significant reduction in the company's net 2025 Marketplace risk adjustment revenue transfer estimate, an issue that first came to light when Centene withdrew its full-year guidance on July 1st. The company's performance prompted a series of downgrades from Wall Street, with firms like UBS, Wells Fargo, and Morgan Stanley also cutting their price targets, signaling widespread concern over the company's ability to restore its earnings trajectory.
Jaypirca had an overall response rate better than AbbVie’s Imbruvica in the study, meaning a higher percentage of patients treated with Jaypirca experienced their cancer shrink or disappear after treatment.
The deal could be announced as early as later this week, according to a report by The Wall Street Journal, which estimates that CyberArk could be valued at over $20 billion.
JPMorgan Chase is in late-stage negotiations to take over Apple's credit card partnership, per a WSJ report. The discussions, which began in early 2024, have reportedly accelerated.
Qualcomm heads into earnings with bullish analyst upgrades, a steady uptrend, and breakout potential. This report could finally unlock its next leg higher.
Investing in dividend-paying ETFs can be a great way to achieve diversification and generate passive income no matter what the broader market is doing.
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Anthony Scaramucci, the founder of SkyBridge Capital, said Monday that JPMorgan Chase & Co.’s (NYSE:JPM) reported plan to allow clients to borrow against their Bitcoin (CRYPTO:
Shares of department store chain Dillard’s (NYSE:DDS)
jumped 3% in the afternoon session after JPMorgan Chase & Co. raised its price target on the retailer. Investment analysts at the firm increased their price objective to $458.00 from $368.00, citing a strong end to the quarter that was driven by a rise in consumer activity in July. Despite the upgraded price target, JPMorgan maintained its 'underweight' rating, which signaled a continued cautious outlook on the stock's performance relative to the market. The market reacted positively to the price target change, and the shares reached a new all-time high of $511.02 during the session.
Shares of clothing and footwear retailer Boot Barn (NYSE:BOOT)
jumped 3.1% in the morning session after analysts at JPMorgan Chase & Co. and Piper Sandler raised their price targets on the stock, signaling confidence in the company's outlook.
Shares of IREN Limited (NASDAQ: IREN) are trading lower Monday following a downgrade from JPMorgan, which lowered its rating on the stock from Overweight to Neutral.
Shares of Royal Caribbean have risen 52% so far this year and jumped more than 125% in the last 12 months, driven by steady cruise demand and higher ticket prices.
The JPMorgan Equity Premium Income ETF fund rose and is nearing its all-time high. JEPI was trading at $57.2, a few points below the all-time high of $57.56, up by almost 20% from its lowest level in April this year.
